363 related articles for article (PubMed ID: 19609466)
1. An unbalanced portfolio.
Federsel HJ
Drug News Perspect; 2009 Jun; 22(5):287-92. PubMed ID: 19609466
[TBL] [Abstract][Full Text] [Related]
2. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
Betz UA
Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
[TBL] [Abstract][Full Text] [Related]
3. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
4. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
5. A decade of fragment-based drug design: strategic advances and lessons learned.
Hajduk PJ; Greer J
Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284
[TBL] [Abstract][Full Text] [Related]
6. What is the most important approach in current drug discovery: doing the right things or doing things right?
Elebring T; Gill A; Plowright AT
Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
[TBL] [Abstract][Full Text] [Related]
7. Portfolio analysis and R&D decision making.
Evans R; Hinds S; Hammock D
Nat Rev Drug Discov; 2009 Mar; 8(3):189-90. PubMed ID: 19182818
[No Abstract] [Full Text] [Related]
8. Open PHACTS: semantic interoperability for drug discovery.
Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
[TBL] [Abstract][Full Text] [Related]
9. Selection of licensing candidates in the pharmaceutical industry: an application of the analytic hierarchy process.
Ross ME; Nydick RL
J Health Care Mark; 1992 Jun; 12(2):60-5. PubMed ID: 10119215
[TBL] [Abstract][Full Text] [Related]
10. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
11. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
Forster SP; Stegmaier J; Spycher R; Seeger S
Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
[TBL] [Abstract][Full Text] [Related]
12. Alternative business models for drug discovery.
Bunin BA; Ekins S
Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585
[No Abstract] [Full Text] [Related]
13. The global portfolio of new antimalarial medicines under development.
Olliaro P; Wells TN
Clin Pharmacol Ther; 2009 Jun; 85(6):584-95. PubMed ID: 19404247
[TBL] [Abstract][Full Text] [Related]
14. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry.
Stone JA; Banfield C; Pfister M; Tannenbaum S; Allerheiligen S; Wetherington JD; Krishna R; Grasela DM
J Clin Pharmacol; 2010 Sep; 50(9 Suppl):20S-30S. PubMed ID: 20881214
[TBL] [Abstract][Full Text] [Related]
15. Payers growing influence on R&D decision making.
Hughes B
Nat Rev Drug Discov; 2008 Nov; 7(11):876-8. PubMed ID: 18974741
[No Abstract] [Full Text] [Related]
16. Compound scale-up at the discovery-development interface.
Nikitenko AA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
[TBL] [Abstract][Full Text] [Related]
17. To measure is to know: an approach to CADD performance metrics.
Loughney D; Claus BL; Johnson SR
Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
[TBL] [Abstract][Full Text] [Related]
18. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
[TBL] [Abstract][Full Text] [Related]
19. Organizing for innovation: towards successful translational research.
West W; Nightingale P
Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
[TBL] [Abstract][Full Text] [Related]
20. Efficient and effective compound management to support lead optimization.
Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
